The report entitled “US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)”, provides analysis of the US lymphedema market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the US Pneumatic Compression Device (PCD) market, by value, by device adoption, by players, etc. —
Complete report on Lymphedema market spread across 50 pages providing 4 company profiles and 2 tables and 19 figures is now available at http://www.marketreportsonline.com/501470.html.
Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall US lymphedema market has also been forecasted for the years 2016-2020, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.
Tactile is the only company providing the Advanced PC device, named Flexitouch. The other key companies in the market are Bio Compression System, Wright Therapy Products and Lympha Press, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Company Coverage of Lymphedema Market:
• Tactile Medical
• Bio Compression System
• Lympha Press (Mego Afek)
• Wright Therapy Products (BSN Medical)
Lymphedema is when excess lymphatic fluid gets collected in the tissues under the skin, which causes swelling. Generally, lymphedema occurs due to the damage or removal of lymph nodes, as a part of cancer surgery.
Lymphedema can be divided into 4 stages, based on the swelling it causes and its severity. There are two types of lymphedema: Primary Lymphedema and Secondary Lymphedema. Primary lymphedema is detected in the children and it is generally the result of an error in the development of the lymphatic system. Secondary lymphedema represents more than 99% of the total cases. It occurs due to the cancer treatment or surgery, resulting in the removal of lymph nodes.
Place a direct purchase order on this “US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) (2016-2021)” report at USD 850 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=501470.
There are many options of treatment of lymphedema available today. These can be used as a single option, and/or in combinations. Treatment of Lymphedema includes: Controlled Compression Therapy, Manual Lymph Drainage (MLD), Complete Decongestive Therapy (CDT) and Pneumatic Compression (PC). PCD are the devices which deliver intermittent pressure through varying inflation and deflation chambers, to move the lymph fluid from extremity and to avoid the adverse consequences of uncontrolled lymphedema.
The US lymphedema market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The US lymphedema market is supported by various growth drivers, such as increasing per capita healthcare expenditure in the US, sever long term effects of non treatment of lymphedema, increasing cancer cases every year, etc. Yet, the market faces certain challenges, such as, reimbursement issues, low awareness, etc.
Key Topics Covered in US Lymphedema Market with Focus on the Pneumatic Compression Device (PCD) Research Report:
1. Executive Summary
3. Market Analysis
4. Market Dynamics
5. Competitive Landscape
6. Company Profiling
Browse All Latest Daedal Research Market Research Reports at http://www.marketreportsonline.com/publisher/daedal-research-market-research.html.
Release ID: 133961